insights_auto
Why is BOT down २०.००%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.००८०
arrow_downward
-२०.००%(-०.००२०) 1D
नोभेम्बर २०, १६:१०:०७ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.२१ करोड
Avg. vol.
१.११ करोड
Volume
८५.९६ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.२१ करोड
Avg. vol.
१.११ करोड
Volume
८५.९६ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
Barron's
·
५२ मिनेट पहिले
S&P 500 Skid Enters Seventh Day as Dow Nears Correction
Coinpaper
·
४४ मिनेट पहिले
S&P 500 Price Prediction: S&P 500 Falls 2.3% Below 200-Day Average
TradingView
·
३८ मिनेट पहिले
S&P 500 is on track for the worst week since the April 2025 'Liberation Day' sell-off
ChartMill
·
१ घण्टा पहिले
S&P 500 Premarket Movers Friday: Gainers and Losers
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd